Tidemark LLC raised its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 101.5% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 395 shares of the exchange traded fund’s stock after acquiring an additional 199 shares during the period. Tidemark LLC’s holdings in SPDR S&P Biotech ETF were worth $39,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. Quintet Private Bank Europe S.A. purchased a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $40,000. ORG Partners LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the second quarter valued at about $40,000. ORG Wealth Partners LLC purchased a new stake in SPDR S&P Biotech ETF during the third quarter worth about $44,000. Waldron Private Wealth LLC acquired a new position in SPDR S&P Biotech ETF during the third quarter worth about $54,000. Finally, Resources Management Corp CT ADV grew its position in SPDR S&P Biotech ETF by 30.3% during the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after buying an additional 138 shares during the period.
SPDR S&P Biotech ETF Trading Up 0.5 %
XBI stock opened at $92.25 on Monday. The firm has a 50 day moving average of $98.95 and a 200-day moving average of $96.17. The company has a market cap of $7.03 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12-month low of $71.98 and a 12-month high of $105.47.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- What is the FTSE 100 index?
- 3 Ultra-High Dividend Yield Stocks for the New Year
- What Are the U.K. Market Holidays? How to Invest and Trade
- Is Boeing Stock a Buy? 5 Pros and 1 Big Risk to Watch in 2024
- What is the S&P/TSX Index?
- Palantir Stock Surges After Announcing Move to the NASDAQ
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.